Housing Conference
Green Coast
Top Women
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen shares top $100 as fears fade over biosimilars

By   /   Friday, April 5th, 2013  /   Comments Off

    Print       Email


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Haas revs up Formula One to expand globally

Read More →